Version 1
: Received: 27 September 2024 / Approved: 27 September 2024 / Online: 29 September 2024 (11:08:01 CEST)
How to cite:
Sciortino, S.; Graham, S.; Bishop, T.; Matteson, J.; Carter, S.; Wu, C. H.; Sharma, R. CF Screening Efficacy and Seasonal Variation in California: 15-Year Comparison of IRT Cutoffs Versus Daily Percentile for First-Tier Testing. Preprints2024, 2024092278. https://doi.org/10.20944/preprints202409.2278.v1
Sciortino, S.; Graham, S.; Bishop, T.; Matteson, J.; Carter, S.; Wu, C. H.; Sharma, R. CF Screening Efficacy and Seasonal Variation in California: 15-Year Comparison of IRT Cutoffs Versus Daily Percentile for First-Tier Testing. Preprints 2024, 2024092278. https://doi.org/10.20944/preprints202409.2278.v1
Sciortino, S.; Graham, S.; Bishop, T.; Matteson, J.; Carter, S.; Wu, C. H.; Sharma, R. CF Screening Efficacy and Seasonal Variation in California: 15-Year Comparison of IRT Cutoffs Versus Daily Percentile for First-Tier Testing. Preprints2024, 2024092278. https://doi.org/10.20944/preprints202409.2278.v1
APA Style
Sciortino, S., Graham, S., Bishop, T., Matteson, J., Carter, S., Wu, C. H., & Sharma, R. (2024). CF Screening Efficacy and Seasonal Variation in California: 15-Year Comparison of IRT Cutoffs Versus Daily Percentile for First-Tier Testing. Preprints. https://doi.org/10.20944/preprints202409.2278.v1
Chicago/Turabian Style
Sciortino, S., Cindy H. Wu and Rajesh Sharma. 2024 "CF Screening Efficacy and Seasonal Variation in California: 15-Year Comparison of IRT Cutoffs Versus Daily Percentile for First-Tier Testing" Preprints. https://doi.org/10.20944/preprints202409.2278.v1
Abstract
The California Genetic Disease Screening Program (GDSP) employs a fixed immunoreactive trypsinogen (IRT) cutoff followed by molecular testing to screen newborns for Cystic Fibrosis (CF). The cutoffs approximate a 1.6% yearly IRT screen positive rate, however seasonal variation in IRT population means led us to develop a model to establish fixed IRT cutoffs that anticipate seasonal variation and minimize missed cases below cutoff. We utilized an ARIMA model to fit monthly IRT screen-positive percentiles and estimated regular seasonal expectations. We established a retrospective cohort followed for at least 1.5 years to capture missed false negative CF cases. We compared missed CF cases identified by seasonal cutoffs vs floating cutoffs. GDSP screened 7,410,016 newborns, from July 2007 to Dec. 2022, and missed 36 CF cases below the fixed cutoff; five of the 36 were within 3 ng/mL below the cutoff. There was a regular, seasonal cycle that varied from 1.4% in summer to 1.8% in winter. We would have missed 59 CF cases using a 1.6% daily floating cutoff. California would need to use a 4% daily floating cutoff to improve our current detection rate which would double the number of specimens sent for costly molecular analysis.
Public Health and Healthcare, Public Health and Health Services
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.